Quick Answer
LIFECORE BIOMEDICAL, INC. \DE\ reported Gross Profit of $40.30 million for the year ending 2025.
- LIFECORE BIOMEDICAL, INC. \DE\ showed a decrease of -3.7% in Gross Profit from 2024 to 2025.
- This data is from LIFECORE BIOMEDICAL, INC. \DE\'s annual report (Form 10-K), filed with the SEC on August 7, 2025.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2016: $12.93 million | Q2 2016: $22.78 million | Q3 2016: $20.12 million | Q4 2016: $17.10 million | Q1 2017: $22.87 million | Q2 2017: $19.12 million | Q3 2017: $18.80 million | Q4 2017: $14.92 million | Q1 2018: $19.81 million | Q2 2018: $24.81 million | Q3 2018: $16.34 million | Q4 2018: $16.89 million | Q1 2019: $21.57 million | Q2 2019: $26.21 million | Q3 2019: $15.34 million | Q4 2019: $15.51 million | Q1 2020: $20.05 million | Q2 2020: $24.09 million | Q3 2020: $5.29 million | Q4 2020: $10.77 million | Q1 2021: $10.93 million | Q2 2021: $14.58 million | Q3 2021: $5.55 million | Q4 2021: $11.46 million | Q1 2022: $11.64 million | Q2 2022: $10.42 million | Q3 2022: $5.98 million | Q4 2022: $5.68 million | Q1 2023: $8.55 million | Q2 2023: $7.78 million | Q3 2023: $2.73 million | Q4 2023: $9.96 million | Q1 2024: $11.89 million | Q3 2024: $5.39 million | Q4 2024: $11.08 million | Q1 2025: $9.85 million | Q3 2025: $7.79 million.
- Over the full 16 years of available data (2010 to 2025), LIFECORE BIOMEDICAL, INC. \DE\'s Gross Profit has grown by 19.3%.
- Historical annual values: Fiscal year 2025: $40.30 million | Fiscal year 2024: $41.85 million | Fiscal year 2023: $27.99 million | Fiscal year 2022: $39.07 million | Fiscal year 2021: $38.94 million | Fiscal year 2020: $39.39 million | Fiscal year 2019: $81.00 million | Fiscal year 2018: $78.34 million | Fiscal year 2017: $79.21 million | Fiscal year 2016: $66.78 million | Fiscal year 2015: $65.41 million | Fiscal year 2014: $62.56 million | Fiscal year 2013: $62.76 million | Fiscal year 2012: $52.14 million | Fiscal year 2011: $46.70 million | Fiscal year 2010: $33.77 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: